<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<REGINFO_RIN_DATA xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" RUN_DATE="2026-04-03-04:00" xsi:noNamespaceSchemaLocation="https://www.reginfo.gov/public/xml/REGINFO_XML_Ver10262011.xsd">
    <RIN_INFO>
        <RIN>3041-AD89</RIN>
        <PUBLICATION>
            <PUBLICATION_ID>202304</PUBLICATION_ID>
            <PUBLICATION_TITLE>Unified Agenda of Federal Regulatory and Deregulatory Actions</PUBLICATION_TITLE>
        </PUBLICATION>
        <AGENCY>
            <CODE>3041</CODE>
            <NAME>Consumer Product Safety Commission</NAME>
            <ACRONYM>CPSC</ACRONYM>
        </AGENCY>
        <RULE_TITLE>Infant Pillow Ban</RULE_TITLE>
        <ABSTRACT><![CDATA[<!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>The Commission has established an Infant Pillow Ban (16 CFR part 1500.18(a)(16)), which bans infant pillows with all of the following characteristics: (1) a flexible fabric covering, (2) loosely filled with a granular material such as plastic foam beads or pellets, (3) easily flattened, (4) capable of conforming to the body or face of an infant, and (5) intended or promoted for the use by children under one year of age. In fiscal year 2023, staff intends to submit to the Commission a briefing package recommending issuance of a notice of proposed rulemaking (NPRM) regarding expanding the ban to include certain hazardous infant pillows currently allowed in the marketplace.</p>
</body>
</html>]]></ABSTRACT>
        <PRIORITY_CATEGORY>Substantive, Nonsignificant</PRIORITY_CATEGORY>
        <RIN_STATUS>Previously Published in The Unified Agenda</RIN_STATUS>
        <RULE_STAGE>Proposed Rule Stage</RULE_STAGE>
        <MAJOR>Undetermined</MAJOR>
        <UNFUNDED_MANDATE_LIST>
            <UNFUNDED_MANDATE>No</UNFUNDED_MANDATE>
        </UNFUNDED_MANDATE_LIST>
        <CFR_LIST>
            <CFR>16 CFR 1500.18(a)(16)</CFR>
        </CFR_LIST>
        <LEGAL_AUTHORITY_LIST>
            <LEGAL_AUTHORITY>15 U.S.C. 1261</LEGAL_AUTHORITY>
        </LEGAL_AUTHORITY_LIST>
        <LEGAL_DLINE_LIST/>
        <RPLAN_ENTRY>No</RPLAN_ENTRY>
        <TIMETABLE_LIST>
            <TIMETABLE>
                <TTBL_ACTION>Staff Sends NPRM Briefing Package to Commission</TTBL_ACTION>
                <TTBL_DATE>09/00/2023</TTBL_DATE>
            </TIMETABLE>
        </TIMETABLE_LIST>
        <RFA_REQUIRED>Undetermined</RFA_REQUIRED>
        <GOVT_LEVEL_LIST>
            <GOVT_LEVEL>Undetermined</GOVT_LEVEL>
        </GOVT_LEVEL_LIST>
        <FEDERALISM>Undetermined</FEDERALISM>
        <PRINT_PAPER>No</PRINT_PAPER>
        <INTERNATIONAL_INTEREST>No</INTERNATIONAL_INTEREST>
        <AGENCY_CONTACT_LIST>
            <CONTACT>
                <FIRST_NAME>Ashley</FIRST_NAME>
                <LAST_NAME>Johnson</LAST_NAME>
                <TITLE>Project Manager, Division of Pharmacology and Physiology Assessment</TITLE>
                <AGENCY>
                    <CODE>3041</CODE>
                </AGENCY>
                <PHONE>301 504-7872</PHONE>
                <EMAIL>aajohnson@cpsc.gov</EMAIL>
                <MAILING_ADDRESS>
                    <STREET_ADDRESS>National Product Testing and Evaluation Center, 5 Research Place,</STREET_ADDRESS>
                    <CITY>Rockville</CITY>
                    <STATE>MD</STATE>
                    <ZIP>20850</ZIP>
                </MAILING_ADDRESS>
            </CONTACT>
        </AGENCY_CONTACT_LIST>
    </RIN_INFO>
</REGINFO_RIN_DATA>
